Faulty exon splicing is cause of rare subtype of Parkinson's disease, pointing to new drug targets Sep. 14, 2020
Topline data presented from study 402 of lumateperone in patients with bipolar depression Sep. 10, 2020
New Nav1.8 channel blockers patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical Sep. 8, 2020
Australian funding to support Pharmaxis' development of PXS-4699 for Duchenne muscular dystrophy Sep. 7, 2020
RSS